GSK plc (GSK) Financials

GSK Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 95.7 billion 71.2 billion
June 30, 2026 81.3 billion 58.7 billion
March 31, 2026 109.4 billion 79.1 billion
Dec. 31, 2025 82.0 billion 60.5 billion

GSK Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 3.2 billion ?
June 30, 2026 2.9 billion ?
March 31, 2026 921.4 million ?
Dec. 31, 2025 2.0 billion ?

GSK Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 2.0 billion
June 30, 2026 579.3 million
March 31, 2026 2.4 billion
Dec. 31, 2025 843.5 million

GSK Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 4.0 billion 29.0 billion -
June 30, 2026 4.1 billion 18.4 billion -
March 31, 2026 6.0 billion 24.4 billion -
Dec. 31, 2025 4.6 billion 19.7 billion 1.1 billion

GSK Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 2.7 billion
June 30, 2026 2.7 billion
March 31, 2026 2.7 billion
Dec. 31, 2025 2.7 billion

GSK Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 493.9 million 2.5 billion 3.2 billion -
June 30, 2026 435.8 million 4.6 billion 2.9 billion -
March 31, 2026 584.8 million 2.2 billion 2.8 billion -
Dec. 31, 2025 752.9 million 3.2 billion 3.5 billion -

GSK Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 11.7 billion 3.0 billion
June 30, 2026 11.1 billion 3.0 billion
March 31, 2026 10.1 billion 2.5 billion
Dec. 31, 2025 11.6 billion 3.6 billion

GSK

Price: $48.26

52 week price:
42.85
61.70

Dividend Yield: 3.70%

5-year range yield:
3.48%
10.26%

Forward Dividend Yield: 3.78%

Payout Ratio: 52.47%

Payout Ratio Range:
-1055.17%
938.88%

Dividend Per Share: 1.81 USD

Earnings Per Share: 2.87 USD

P/E Ratio: 17.12

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United Kingdom

Volume: 3.7 million

Ebitda: 2.0 billion

Market Capitalization: 98.4 billion

Average Dividend Frequency: 4

Years Paying Dividends: 43

DGR3: -1.69%

DGR5: -5.85%

DGR10: -4.42%

DGR20: 0.33%

Links: